▶ 調査レポート

処方レンズのグローバル市場(~2027):遠近両用レンズ、プログレッシブレンズ、単眼レンズ、3焦点レンズ

• 英文タイトル:Prescription Lens Market Research Report by Type, Application, Coating, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが調査・発行した産業分析レポートです。処方レンズのグローバル市場(~2027):遠近両用レンズ、プログレッシブレンズ、単眼レンズ、3焦点レンズ / Prescription Lens Market Research Report by Type, Application, Coating, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 / MRC2304F162資料のイメージです。• レポートコード:MRC2304F162
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、252ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の本調査レポートによると、2021年に212.9億ドルであった世界の処方レンズ市場規模は2022年に229.4億ドルになり、更に年平均7.93%拡大して2027年までに336.5億ドルに達する見通しです。本書は、処方レンズの世界市場についての多面的な調査を元に、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別(遠近両用レンズ、プログレッシブレンズ、単眼レンズ、3焦点レンズ)分析、用途別(乱視、遠視/遠視、近視、老眼)分析、コーティング別(防曇コーティング、反射防止コーティング、耐スクラッチコーティング、紫外線処理コーティング)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの内容をまとめた市場調査レポートです。なお、本書に掲載されている企業情報には、Carl Zeiss AG、Charmant Inc.、De Rigo Vision S.p.A.、Essilor International S.A.、Fielmann AG、HOYA VISION CARE COMPANY、Insight Equity A. P. X, L P、JEANNE LANVIN SA、Kyboe、Luxottica group、Marchon Eyewear, Inc.、Marcolin SpA.などが含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の処方レンズ市場規模:種類別
- 遠近両用レンズの市場規模
- プログレッシブレンズの市場規模
- 単眼レンズの市場規模
- 3焦点レンズの市場規模
・世界の処方レンズ市場規模:用途別
- 乱視における市場規模
- 遠視/遠視における市場規模
- 近視における市場規模
- 老眼における市場規模
・世界の処方レンズ市場規模:コーティング別
- 防曇コーティングの市場規模
- 反射防止コーティングの市場規模
- 耐スクラッチコーティングの市場規模
- 紫外線処理コーティングの市場規模
・世界の処方レンズ市場規模:地域別
- 南北アメリカの処方レンズ市場規模
アメリカの処方レンズ市場規模
カナダの処方レンズ市場規模
ブラジルの処方レンズ市場規模
...
- アジア太平洋の処方レンズ市場規模
日本の処方レンズ市場規模
中国の処方レンズ市場規模
インドの処方レンズ市場規模
韓国の処方レンズ市場規模
台湾の処方レンズ市場規模
...
- ヨーロッパ/中東/アフリカの処方レンズ市場規模
イギリスの処方レンズ市場規模
ドイツの処方レンズ市場規模
フランスの処方レンズ市場規模
ロシアの処方レンズ市場規模
...
- その他地域の処方レンズ市場規模
・競争状況
・企業情報

The Global Prescription Lens Market size was estimated at USD 21.29 billion in 2021 and expected to reach USD 22.94 billion in 2022, and is projected to grow at a CAGR 7.93% to reach USD 33.65 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Prescription Lens to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Bifocal, Progressive, Single vision, Trifocal, and Workspace progressives. The Single vision is further studied across Concave, Convex, and Cylindrical.

Based on Application, the market was studied across Astigmatism, Hyperopia/Hypermetropia, Myopia, and Presbyopia.

Based on Coating, the market was studied across Anti-fog coating, Anti-reflective, Scratch resistant coating, and Ultraviolet treatment.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Prescription Lens market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Prescription Lens Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Prescription Lens Market, including Carl Zeiss AG, Charmant Inc., De Rigo Vision S.p.A., Essilor International S.A., Fielmann AG, HOYA VISION CARE COMPANY, Insight Equity A. P. X, L P, JEANNE LANVIN SA, Kyboe, Luxottica group, Marchon Eyewear, Inc., Marcolin SpA., MAUI JIM, INC., Michael Kors (USA), Inc., Prive Goods, LLC, Rodenstock GmbH, Safilo Group S.p.A., Seiko Optical Products Co Ltd, Specsavers Optical Group Ltd, The Eastman Kodak Company, Titan Company Limited., Transitions Optical, VISION EASE, Vision Rx Lab, and XIAMEN ASA SUNGLASSES CO., LTD..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Prescription Lens Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Prescription Lens Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Prescription Lens Market?
4. What is the competitive strategic window for opportunities in the Global Prescription Lens Market?
5. What are the technology trends and regulatory frameworks in the Global Prescription Lens Market?
6. What is the market share of the leading vendors in the Global Prescription Lens Market?
7. What modes and strategic moves are considered suitable for entering the Global Prescription Lens Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing occurrence of reflective error cases such as myopia and astigmatism
5.1.1.2. Rise in the number of eye problems with increased screen-time of computers and gadgets
5.1.1.3. Growing acceptance and use of eyewear products
5.1.2. Restraints
5.1.2.1. High cost of prescription lens
5.1.3. Opportunities
5.1.3.1. Technological advancements in prescription lens coupled with presence of online platforms for vision testing
5.1.3.2. Increasing living standards among young population with the need for trending sunglasses and lens
5.1.4. Challenges
5.1.4.1. Possible risks form prescription lenses
5.2. Cumulative Impact of COVID-19

6. Prescription Lens Market, by Type
6.1. Introduction
6.2. Bifocal
6.3. Progressive
6.4. Single vision
6.5.1. Concave
6.5.2. Convex
6.5.3. Cylindrical
6.5. Trifocal
6.6. Workspace progressives

7. Prescription Lens Market, by Application
7.1. Introduction
7.2. Astigmatism
7.3. Hyperopia/Hypermetropia
7.4. Myopia
7.5. Presbyopia

8. Prescription Lens Market, by Coating
8.1. Introduction
8.2. Anti-fog coating
8.3. Anti-reflective
8.4. Scratch resistant coating
8.5. Ultraviolet treatment

9. Americas Prescription Lens Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Prescription Lens Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Prescription Lens Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Carl Zeiss AG
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Charmant Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. De Rigo Vision S.p.A.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Essilor International S.A.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Fielmann AG
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. HOYA VISION CARE COMPANY
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Insight Equity A. P. X, L P
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. JEANNE LANVIN SA
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Kyboe
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Luxottica group
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Marchon Eyewear, Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Marcolin SpA.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. MAUI JIM, INC.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Michael Kors (USA), Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Prive Goods, LLC
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Rodenstock GmbH
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Safilo Group S.p.A.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Seiko Optical Products Co Ltd
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Specsavers Optical Group Ltd
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. The Eastman Kodak Company
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Titan Company Limited.
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Transitions Optical
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. VISION EASE
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Vision Rx Lab
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. XIAMEN ASA SUNGLASSES CO., LTD.
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing